Stock NEO NEOGENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages NeoGenomics, Inc.

Equities

NEO

US64049M2098

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-05-03 EDT 		5-day change 1st Jan Change
15.3 USD +3.94% Intraday chart for NeoGenomics, Inc. +8.20% -5.44%
05-02 North American Morning Briefing : Stock Futures -3- DJ
04-30 Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NeoGenomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
NeoGenomics, Inc. Reaffirms Consolidated Earnings Guidance for the Full Year 2024
NeoGenomics, Inc. Announces Senior Leadership Promotions
NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics
Traders Await Fed Minutes, Nvidia Earnings as US Equity Futures Drop Pre-Bell
NeoGenomics Swings to Q4 Adjusted Earnings, Revenue Rises; Issues 2024 Guidance
NeoGenomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
NeoGenomics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
NeoGenomics, Inc. Provides Earnings Guidance for the Year 2024
Neogenomics, Inc. and Concertai, Llc Announce Collaboration to Advance Population-Scale, Definitive Hematological Research & Generative Ai Solutions At Ash 2023
Sector Update: Health Care Stocks Rise in Late Afternoon
Top Midday Decliners
NeoGenomics Shares Fall; Company to Appeal Preliminary Injunction in Natera Copyright Battle
Sector Update: Health Care Stocks Steady Premarket Thursday
NeoGenomics to Appeal Preliminary Injunction in Natera Copyright Battle
Sector Update: Health Care Stocks Advance Thursday Afternoon
Natera Winning RaDaR Preliminary Injunction Bodes Poorly for NeoGenomics, Needham Says
Natera Wins Preliminary Injunction in Copyright Battle Against NeoGenomics
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday
NeoGenomics Swings to Breakeven Q3 Adjusted Earnings, Revenue Rises; 2023 Revenue Outlook Lifted
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEO Stock
  4. News NeoGenomics, Inc.
  5. Other languages